Fusion of the FUS and BBF2H7 genes in low grade fibromyxoid sarcoma.

The FUS gene at 16p11 fuses with DDIT3 and ATF1 as the result of translocations with chromosome band 12q13 in myxoid liposarcoma and angiomatoid fibrous histiocytoma, respectively, and with ERG as the result of a t(16;21)(p11;q22) in acute myeloid leukemia. We here show that a t(7;16)(q33;p11) in two cases of low grade fibromyxoid sarcoma fuses the FUS gene to BBF2H7, a previously uncharacterized gene that is homologous to the Drosophila Bbf-2 gene. BBF2H7 spans more than 120 kbp genomic DNA, is composed of 12 exons and contains a 1560 bp open reading frame. It codes for a 519 amino acid protein that contains a basic DNA binding and leucine zipper dimerization (B-ZIP) motif, highly similar to that in the OASIS, CREB-H, CREB4 and CREB3 transcription factors, followed by a hydrophobic region predicted to be an alpha-helical transmembrane domain. Reverse transcription-polymerase chain reaction (RT-PCR), using FUS forward and BBF2H7 reverse primers, amplified FUS/BBF2H7 chimeric transcripts composed of the first five exons and part of exon 6 of FUS and part of exon 5 and exons 6-12 of BBF2H7. The FUS/BBF2H7 chimera codes for a protein containing the N-terminus of FUS and the B-ZIP domain and the C-terminus of BBF2H7.

[1]  A. Wanaka,et al.  Expression of OASIS, a CREB/ATF family transcription factor, in CNS lesion and its transcriptional activity. , 2002, Brain research. Molecular brain research.

[2]  C. Vinson,et al.  Classification of Human B-ZIP Proteins Based on Dimerization Properties , 2002, Molecular and Cellular Biology.

[3]  I. Panagopoulos,et al.  Fusion of the FUS and ATF1 Genes in a Large, Deep-Seated Angiomatoid Fibrous Histiocytoma , 2002, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[4]  C. Ji,et al.  Molecular cloning and characterization of a novel human cAMP response element-binding (CREB) gene (CREB4) , 2002, Journal of Human Genetics.

[5]  A. Tanigami,et al.  OASIS is a transcriptional activator of CREB/ATF family with a transmembrane domain. , 2002, Biochemical and biophysical research communications.

[6]  Y. Labrie,et al.  AIbZIP, a novel bZIP gene located on chromosome 1q21.3 that is highly expressed in prostate tumors and of which the expression is up-regulated by androgens in LNCaP human prostate cancer cells. , 2002, Cancer research.

[7]  A. Tanigami,et al.  CREB-H: a novel mammalian transcription factor belonging to the CREB/ATF family and functioning via the box-B element with a liver-specific expression. , 2001, Nucleic acids research.

[8]  H. Tanke,et al.  Characterization of chromosome aberrations in salivary gland tumors by FISH, including multicolor COBRA‐FISH , 2001, Genes, chromosomes & cancer.

[9]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[10]  F. Mertens,et al.  A novel FUS/CHOP chimera in myxoid liposarcoma. , 2000, Biochemical and biophysical research communications.

[11]  P. Lichter,et al.  Low grade fibromyxoid sarcoma: A further low-grade soft tissue malignancy characterized by a ring chromosome , 2000 .

[12]  B. Waters,et al.  Genetic characterization of angiomatoid fibrous histiocytoma identifies fusion of the FUS and ATF-1 genes induced by a chromosomal translocation involving bands 12q13 and 16p11. , 2000, Cancer genetics and cytogenetics.

[13]  P. Åman,et al.  Fusion genes in solid tumors. , 1999, Seminars in cancer biology.

[14]  V. Misra,et al.  Luman, a new member of the CREB/ATF family, binds to herpes simplex virus VP16-associated host cellular factor , 1997, Molecular and cellular biology.

[15]  D. Immanuel,et al.  A topogenic role for the oncogenic N-terminus of TLS: nucleolar localization when transcription is inhibited , 1997, Oncogene.

[16]  M. Höglund,et al.  Expression patterns of the human sarcoma-associated genes FUS and EWS and the genomic structure of FUS. , 1996, Genomics.

[17]  M. Höglund,et al.  Fusion of the EWS and CHOP genes in myxoid liposarcoma. , 1996, Oncogene.

[18]  S. Mori,et al.  Chimeric TLS/FUS-CHOP gene expression and the heterogeneity of its junction in human myxoid and round cell liposarcoma. , 1995, The American journal of pathology.

[19]  M. Höglund,et al.  Characterization of the CHOP breakpoints and fusion transcripts in myxoid liposarcomas with the 12;16 translocation. , 1994, Cancer research.

[20]  M. Höglund,et al.  Fusion of the FUS gene with ERG in acute myeloid leukemia with t(16;21)(p11;q22) , 1994, Genes, chromosomes & cancer.

[21]  H. Zinszner,et al.  A novel effector domain from the RNA-binding protein TLS or EWS is required for oncogenic transformation by CHOP. , 1994, Genes & development.

[22]  Y. Hayashi,et al.  An RNA-binding protein gene, TLS/FUS, is fused to ERG in human myeloid leukemia with t(16;21) chromosomal translocation. , 1994, Cancer research.

[23]  L. Philipson,et al.  CHOP (GADD153) and its oncogenic variant, TLS-CHOP, have opposing effects on the induction of G1/S arrest. , 1994, Genes & development.

[24]  N. Mandahl,et al.  Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma , 1993, Nature.

[25]  R. Larson,et al.  Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma , 1993, Nature Genetics.

[26]  G. Thomas,et al.  Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours , 1992, Nature.

[27]  R E Rose,et al.  A cyclic AMP-responsive element-binding transcriptional activator in Drosophila melanogaster, dCREB-A, is a member of the leucine zipper family , 1992, Molecular and cellular biology.

[28]  T. Maniatis,et al.  A Drosophila CREB/ATF transcriptional activator binds to both fat body- and liver-specific regulatory elements. , 1992, Genes & development.

[29]  F. Mitelman,et al.  Three major cytogenetic subgroups can be identified among chromosomally abnormal solitary lipomas , 1988, Human Genetics.

[30]  M. Kozak.  An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs. , 1987, Nucleic acids research.

[31]  F. Mertens,et al.  World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone , 2002 .

[32]  A. Folpe,et al.  Low grade fibromyxoid sarcoma , 2002 .

[33]  E. Berg,et al.  World Health Organization Classification of Tumours , 2002 .

[34]  P. Marynen,et al.  Molecular characterization of 12p abnormalities in hematologic malignancies: deletion of KIP1, rearrangement of TEL, and amplification of CCND2. , 1996, Blood.

[35]  F. Mitelman.  ISCN 1991 : guidelines for cancer cytogenetics : supplement to An international system for human cytogenetic nomenclature : recommendations of the Standing Committee on Human Cytogenetic Nomenclature, Subcommittee on Cancer Cytogenetics , 1992 .